Production (Stage)
Yubo International Biotech Limited
YBGJ
$0.0612
$0.015233.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -435.60K | -289.70K | -580.80K | -527.50K | -377.30K |
| Total Depreciation and Amortization | 44.60K | 42.40K | 48.40K | 46.00K | 46.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.70K | -67.50K | -54.90K | 160.10K | -32.20K |
| Change in Net Operating Assets | 30.70K | -617.90K | 494.80K | 129.40K | 32.40K |
| Cash from Operations | -392.00K | -932.70K | -92.60K | -192.00K | -330.60K |
| Capital Expenditure | -6.20K | -- | -- | 18.90K | -18.90K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 36.50K | 82.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 11.10K | -11.10K |
| Cash from Investing | -6.20K | 0.00 | 36.50K | 112.00K | -30.00K |
| Total Debt Issued | 277.80K | 1.03M | -- | -- | 210.20K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 76.80K | 25.40K | 174.40K | 98.00K |
| Cash from Financing | 277.80K | 1.11M | 25.40K | 174.40K | 308.20K |
| Foreign Exchange rate Adjustments | 123.20K | -177.70K | 31.10K | -143.70K | 103.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.80K | -1.00K | 300.00 | -49.30K | 50.70K |